Wise Practice of Chinese Hemodialysis (WISHES)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

30000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-12-31

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators are registering all HD patients at recruited hospitals and developing a HD database in China. Patients will be follow-up every 3 months, and both baseline and follow-up information will be entered into the registration system. The patient survival, technical survival, patency rate of access, quality of life and residual renal function for HD patients will be compared using the HD database.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

High-flux Hemodialysis Versus Hemodiafiltration for End-Stage Renal Disease

NCT03456232

Chronic Kidney Failure

UNKNOWN NA

Survey and Reduction of Mortality in Peridialysis Uremic Patients Via Intervention of Risk Factors

NCT04088526

End Stage Renal Disease on Dialysis

UNKNOWN NA

China Q Cohort Study

NCT04197674

End Stage Renal Disease on Dialysis Peritoneal Dialysis Hemodialysis

UNKNOWN

The Clinical Study of Improving the Thirst and Hypotension of Hemodialysis Patients

NCT02583802

Intradialytic Hypotension

UNKNOWN PHASE2/PHASE3

Three Anticoagulation Strategies for Hemodialysis in Patients at Risk of Hemorrhage

NCT03419923

Hemodialysis Anticoagulation

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators are registering all end stage renal disease (ESRD) patients receiving hemodialysis (HD) treatment, and developing a HD database in China. Patients' demographic characteristics (including age, gender, height, weight, BMI, smoking, drinking, and education), clinical characteristics (including systolic blood pressure, diastolic blood pressure, primary cause of ESRD, and lab measurements of serum, urine, and access patency), complications, drug information and scores of quality of life at the baseline will be collected. Patients will be follow-up every 3 month, the demographic and clinical characteristics, complications and drug information of patients will be collected at each visit. The investigators also record the outcome at each visit, such as mortality (including all-cause mortality and cardiovascular disease mortality), technical survival, kidney transplantation, transfer to peritoneal dialysis, hospitalization, access failure，etc. The patient survival, technical survival, patency rate of access, quality of life and residual renal function for HD patients will be compared using the HD database.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Haemolyses and Related Conditions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hemodialysis patients

End stage renal disease patients receiving hemodialysis treatment

No intervention

Intervention Type OTHER

Registration of all HD patients in the First Affiliated Hospital of Sun Yat-sen University and other hospital which have signed the contract in China.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Registration of all HD patients in the First Affiliated Hospital of Sun Yat-sen University and other hospital which have signed the contract in China.

Intervention Type OTHER